Bingo on the VRUS quiz answer with one nitpick. You said:
“pts with sustained eAg seroconversion have a good likelihood of sustained suppression off drug so this arm is eligible for assessment of ‘svr’ ”
The e+ trial does not impose a time constraint on when seroconversion occurs in order to qualify for stopping treatment at 72 weeks and testing for SVR, so I’m nitpicking about your first use of the word sustained in the above excerpt.
p.s. I agree with your use of quotation marks on “SVR.” I assume that you, too, are not convinced that this is the same kind of meaningful SVR as in HCV.
Market Data 
Markets 
AI
